vs
Side-by-side financial comparison of Plymouth Industrial REIT, Inc. (PLYM) and STEM, INC. (STEM). Click either name above to swap in a different company.
Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $47.1M, roughly 1.1× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -106.3%, a 72.4% gap on every dollar of revenue. On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 0.4%).
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
PLYM vs STEM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $51.2M | $47.1M |
| Net Profit | $-54.4M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -102.5% | -17.7% |
| Net Margin | -106.3% | -33.9% |
| Revenue YoY | -1.4% | -15.6% |
| Net Profit YoY | -248.5% | 68.8% |
| EPS (diluted) | $-1.23 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.1M | ||
| Q3 25 | $51.2M | $38.2M | ||
| Q2 25 | $47.2M | $38.4M | ||
| Q1 25 | $45.6M | $32.5M | ||
| Q4 24 | $47.6M | $55.8M | ||
| Q3 24 | $51.9M | $29.3M | ||
| Q2 24 | $48.7M | $34.0M | ||
| Q1 24 | $50.2M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $-54.4M | $-23.8M | ||
| Q2 25 | $-6.1M | $202.5M | ||
| Q1 25 | $5.8M | $-25.0M | ||
| Q4 24 | $147.4M | $-51.1M | ||
| Q3 24 | $-15.6M | $-148.3M | ||
| Q2 24 | $1.3M | $-582.3M | ||
| Q1 24 | $6.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -102.5% | -33.6% | ||
| Q2 25 | -10.3% | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | -29.6% | -493.2% | ||
| Q2 24 | 2.7% | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | -106.3% | -62.2% | ||
| Q2 25 | -12.9% | 527.8% | ||
| Q1 25 | 12.8% | -76.9% | ||
| Q4 24 | 309.9% | -91.6% | ||
| Q3 24 | -30.1% | -506.3% | ||
| Q2 24 | 2.7% | -1712.6% | ||
| Q1 24 | 12.4% | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | $-1.23 | $-2.84 | ||
| Q2 25 | $-0.14 | $-1.79 | ||
| Q1 25 | $0.13 | $-0.15 | ||
| Q4 24 | $3.24 | $-15.29 | ||
| Q3 24 | $-0.35 | $-18.24 | ||
| Q2 24 | $0.03 | $-71.81 | ||
| Q1 24 | $0.14 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $470.1M | $-249.4M |
| Total Assets | $1.6B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $646.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-249.4M | ||
| Q3 25 | $470.1M | $-235.7M | ||
| Q2 25 | $539.6M | $-214.1M | ||
| Q1 25 | $571.0M | $-417.5M | ||
| Q4 24 | $579.5M | $-398.4M | ||
| Q3 24 | $436.5M | $-344.1M | ||
| Q2 24 | $475.2M | $-203.2M | ||
| Q1 24 | $484.6M | $371.6M |
| Q4 25 | — | $308.9M | ||
| Q3 25 | $1.6B | $362.6M | ||
| Q2 25 | $1.6B | $379.2M | ||
| Q1 25 | $1.4B | $405.1M | ||
| Q4 24 | $1.4B | $437.4M | ||
| Q3 24 | $1.5B | $537.8M | ||
| Q2 24 | $1.4B | $691.5M | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.12× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | $20.0M | $11.4M | ||
| Q2 25 | $23.4M | $-21.3M | ||
| Q1 25 | $15.6M | $8.5M | ||
| Q4 24 | $96.1M | $-14.7M | ||
| Q3 24 | $17.6M | $-9.4M | ||
| Q2 24 | $19.9M | $-11.9M | ||
| Q1 24 | $16.6M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | 2.67× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.12× | — | ||
| Q1 24 | 2.67× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
